'Big Shoes To Fill' As Hatch Retirement Leaves Supplement Market Legacy
This article was originally published in The Rose Sheet
Executive Summary
Sen. Orrin Hatch won’t seek re-election and will leave 24 years after Congress passed the Dietary Supplement Health and Education Act as a framework for FDA's regulation of vitamin, mineral and supplement product manufacturing and marketing. Hatch is in his seventh term and is the longest-serving Senate member.
You may also be interested in...
FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework
Commissioner Gottlieb appointed working group at FDA to evaluate agency's existing structure and strategies for oversight of supplement sector. Group's findings will determine extent of potential changes in regulatory authorities agency will ask members of Congress to establish through legislation. Action plan expected in early 2019.
Elections Reshape Congress But Not Supplement Industry Regulatory Outlook
Democrats potentially could target tightening regulatory oversight of some industries after regaining a majority in House, but Trump administration's high priority on reducing regulatory burdens bodes well that legislation to expand FDA's current authorities over the US supplement sector will not emerge before Congress' next session opens in 2021. NJ Democrat Frank Pallone could be member of Congress most commonly mentioned and lobbied by supplement industry during next session as Energy and Commerce chairman.
House And Senate Farm Bills Dilemma: Each Includes One, But Not Both Of Supplement Industry's SNAP, Hemp Goals
Senate's USDA five-year reauthorization would remove hemp from federal list of controlled substances and lift limits on production in the US but does not contain language included in the House bill to make multivitamins eligible for Supplemental Nutrition Assistance Program purchases. House bill though, doesn't clear hemp production. "I think we have a lot of work of ahead of us on both fronts," says CRN President and CEO Steve Mister.